Charles Cameron, Ph.D., is the BCG-TEKNIKA Site Head and Integrated Product Team Lead at Merck, where they lead a diverse team of over 100 in the compliant commercial supply of BCG-Tice, a treatment for urinary bladder cancer. Cameron has extensive experience in GMP production, having previously served in positions such as Director of Engineering and Associate Director of Vaccine Technical Operations, where they successfully oversaw the launch of significant vaccine production facilities and managed multi-million dollar projects. They earned a Ph.D. in Chemical Engineering from the University of Minnesota-Twin Cities and hold dual Bachelor's degrees in Spanish Language and Literature and Chemical Engineering from The Ohio State University, both with honors.
This person is not in the org chart
This person is not in any teams
This person is not in any offices